Mit Lincoln Lab

Nutri Pharmaceuticals Research provides a range of powdered oil pastes, gels, extracts and other liquids for functional and pet food, pharmaceutical, cosmetic and animal feed applications. It utilizes O2P powderization processes and offers more than 50 shelf-stable powders and contract tolling services. Founded in 1994 as a contract packaging company, Nutri Pharmaceuticals Research specializes in providing tabletting and encapsulating services to the small- and medium-sized dietary supplement market. It is also a global supplier of nutritional bioactive products to the food supplement and personal care industries. The company s products include borage, canola, coconut, olive, cod liver, evening primrose, palm, sunflower and safflower oil powders. Nutri Pharmaceuticals Research has operations throughout Nevada.

Boeing Capital Loan Corporation in Las Vegas, NV operates as a subsidiary of The Boeing Company. Specializing in providing financial services, this establishment supports Boeing's global ventures and projects. It plays a vital role in facilitating capital loans and investments that contribute to the company's growth and success. With a strategic focus on financial solutions, Boeing Capital Loan Corporation assists in funding various Boeing initiatives across the commercial, defense, space, and services sectors. Leveraging its expertise and resources, the corporation aids in propelling Boeing's innovative projects forward, ensuring continued advancements in aerospace technology. Generated from the website content

Novum Pharmaceutical Research Services, a distinguished Contract Research Organization (CRO) with over 50 years of experience, specializes in providing comprehensive end-to-end clinical research services for the biotech and pharmaceutical industries. Leveraging an extensive global network and vast therapeutic expertise, Novum efficiently manages complex studies across various therapeutic areas and clinical trial phases. Since its strategic acquisition by Lambda Therapeutic Research in 2019, Novum has reinforced its position in the global CRO market, consistently achieving high-quality research outcomes and maintaining an impeccable regulatory track record. The company is committed to delivering innovative solutions and exceptional client satisfaction, ensuring that their clinical trial management capabilities meet and exceed the evolving needs of their partners. Generated from the website